AXA Investment Managers’s Harmony Biosciences HRMY Stock Holding History

AXA Investment Managers’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.28M	Buy	+82,907	New	+$2.86M	0.01%	745

Other funds holding HRMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXA Investment Managers's HRMY Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Harmony Biosciences (HRMY) in Q3 2025: 82,907 shares worth $2.28M. The stake represents 0.01% of the portfolio and ranks #745 among its holdings.

296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

AXA Investment Managers held 82,907 shares of Harmony Biosciences worth $2.28M as of Q3 2025.
Harmony Biosciences was a new AXA Investment Managers position in Q3 2025.
Harmony Biosciences made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #745 holding.
296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.